PPI Selection for Women Taking NSAIDs
Any proton pump inhibitor (PPI) is appropriate for gastroprotection in women taking NSAIDs, as the guidelines do not differentiate between specific PPI agents or recommend one over another based on sex. The choice of PPI should be guided by the patient's GI risk factors rather than the specific PPI formulation 1.
Risk-Based Algorithm for PPI Use
The decision to prescribe a PPI depends on specific clinical risk factors, not on selecting a particular PPI agent:
For Women Under 65 Years:
- No aspirin use + no prior GI event: NSAID alone is appropriate; PPI is inappropriate 1
- On aspirin OR has prior GI event: NSAID + PPI is appropriate 1
- On aspirin AND has prior GI event: NSAID + PPI is appropriate 1
For Women 65 Years or Older:
- No aspirin + no prior GI event: NSAID + PPI becomes appropriate (age alone increases risk) 1
- On aspirin OR has prior GI event: NSAID + PPI is appropriate 1
- On aspirin AND has prior GI event: NSAID + PPI is appropriate 1
Additional High-Risk Factors Requiring PPI:
- Concurrent corticosteroid use 1
- Concurrent warfarin use 1
- History of complicated GI event (bleeding, perforation) 1
Evidence on PPI Efficacy
PPIs as a class reduce NSAID-induced ulcers by approximately 70% compared to placebo (RR 0.29,95% CI 0.23-0.36) 2. Research confirms that omeprazole, lansoprazole, and other PPIs are effective for both healing and preventing NSAID-related gastroduodenal injury 3, 4, 5. The 2004 guidelines explicitly state that the appropriateness ratings apply to "proton pump inhibitor" as a class, without distinguishing between individual agents 1.
Common Pitfalls to Avoid
Do not prescribe PPIs to low-risk patients (women under 65 with no aspirin use, no prior GI events, and no other risk factors), as this is rated as inappropriate use 1. This represents overuse without clinical benefit and exposes patients to potential long-term PPI adverse effects 6.
Do not assume all women need PPIs simply because they are taking NSAIDs. The evidence clearly stratifies risk based on age, aspirin use, and GI history—not sex 1.
Monitoring Considerations
For patients requiring PPI co-therapy with NSAIDs, monitor for:
- Blood pressure changes (NSAIDs can worsen hypertension) 7
- Renal function in high-risk cases 7
- Recurrence of dyspeptic symptoms
- Iron-deficiency anemia (investigate before starting NSAIDs) 7
Important caveat: If the woman is taking clopidogrel or other thienopyridines, there are additional considerations regarding potential drug interactions with PPIs that may affect cardiovascular outcomes 8, though this does not change which specific PPI to select.